- Home
- ABEO vs PINE Comparison
ABEO vs PINE Comparison
Compare ABEO & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- PINE
- Stock Information
- Founded
- ABEO 1974
- PINE 2019
- Country
- ABEO United States
- PINE United States
- Employees
- ABEO N/A
- PINE N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- PINE Real Estate Investment Trusts
- Sector
- ABEO Health Care
- PINE Real Estate
- Exchange
- ABEO Nasdaq
- PINE Nasdaq
- Market Cap
- ABEO 256.9M
- PINE 220.4M
- IPO Year
- ABEO 1980
- PINE 2019
- Fundamental
- Price
- ABEO $6.00
- PINE $14.64
- Analyst Decision
- ABEO Strong Buy
- PINE Strong Buy
- Analyst Count
- ABEO 6
- PINE 8
- Target Price
- ABEO $18.00
- PINE $19.00
- AVG Volume (30 Days)
- ABEO 1.1M
- PINE 76.4K
- Earning Date
- ABEO 08-11-2025
- PINE 07-24-2025
- Dividend Yield
- ABEO N/A
- PINE 7.79%
- EPS Growth
- ABEO N/A
- PINE N/A
- EPS
- ABEO N/A
- PINE 0.07
- Revenue
- ABEO N/A
- PINE $53,967,000.00
- Revenue This Year
- ABEO N/A
- PINE $8.54
- Revenue Next Year
- ABEO $323.51
- PINE $3.03
- P/E Ratio
- ABEO N/A
- PINE $196.89
- Revenue Growth
- ABEO N/A
- PINE 14.94
- 52 Week Low
- ABEO $3.93
- PINE $14.51
- 52 Week High
- ABEO $7.32
- PINE $19.42
- Technical
- Relative Strength Index (RSI)
- ABEO 48.03
- PINE 38.32
- Support Level
- ABEO $5.49
- PINE $14.56
- Resistance Level
- ABEO $6.11
- PINE $14.94
- Average True Range (ATR)
- ABEO 0.28
- PINE 0.25
- MACD
- ABEO -0.04
- PINE -0.04
- Stochastic Oscillator
- ABEO 47.06
- PINE 10.53
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.